Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Wisch, Julie K.a | Roe, Catherine M.a; d | Babulal, Ganesh M.a; d | Schindler, Suzanne E.a; d | Fagan, Anne M.c; d | Benzinger, Tammie L.b; d | Morris, John C.a; b; d | Ances, Beau M.a; b; c; d; *
Affiliations: [a] Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA | [b] Department of Radiology, Washington University in St. Louis St. Louis, MO, USA | [c] Hope Center, Washington University in Saint Louis, St. Louis, MO, USA | [d] Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
Correspondence: [*] Correspondence to: Beau M. Ances, MD, PhD, MSc, Department of Neurology, Washington University in Saint Louis School of Medicine, Campus Box 8111, 660 South Euclid Avenue, St. Louis, MO 63110, USA. Tel.: 314 747 8423; Fax: 314 747 8427; E-mail: [email protected].
Abstract: Background:Changes in resting state functional connectivity (rs-fc) occur in Alzheimer’s disease (AD), but few longitudinal rs-fc studies have been performed. Most studies focus on single networks and not a global measure of rs-fc. Although the amyloid tau neurodegeneration (AT(N)) framework is increasingly utilized by the AD community, few studies investigated when global rs-fc signature changes occur within this model. Objective:1) Identify a global rs-fc signature that differentiates cognitively normal (CN) individuals from symptomatic AD. 2) Assess when longitudinal changes in rs-fc occur relative to conversion to symptomatic AD. 3) Compare rs-fc with amyloid, tau, and neurodegeneration biomarkers. Methods:A global rs-fc signature composed of intra-network connections was longitudinally evaluated in a cohort of cognitively normal participants at baseline (n = 335). Biomarkers, including cerebrospinal fluid (Aβ42 and tau), structural magnetic resonance imaging, and positron emission tomography were obtained. Results:Global rs-fc signature distinguished CN individuals from individuals who developed symptomatic AD. Changes occurred nearly four years before conversion to symptomatic AD. The global rs-fc signature most strongly correlated with markers of neurodegeneration. Conclusion:The global rs-fc signature changes near symptomatic onset and is likely a neurodegenerative biomarker. Rs-fc changes could serve as a biomarker for evaluating potential therapies for symptomatic conversion to AD.
Keywords: Alzheimer’s disease, biomarkers, neuroimaging, observational studies
DOI: 10.3233/JAD-191039
Journal: Journal of Alzheimer's Disease, vol. 74, no. 4, pp. 1085-1095, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]